Donohue, J. F., Kerwin, E., Barnes, C. N., Moran, E. J., Haumann, B., & Crater, G. D. (2020). Efficacy of revefenacin, a long-acting muscarinic antagonist for nebulized therapy, in patients with markers of more severe COPD: A post hoc subgroup analysis. BMC Pulm Med.
Citação norma ChicagoDonohue, James F., Edward Kerwin, Chris N. Barnes, Edmund J. Moran, Brett Haumann, and Glenn D. Crater. "Efficacy of Revefenacin, a Long-acting Muscarinic Antagonist for Nebulized Therapy, in Patients With Markers of More Severe COPD: A Post Hoc Subgroup Analysis." BMC Pulm Med 2020.
MLA引文Donohue, James F., et al. "Efficacy of Revefenacin, a Long-acting Muscarinic Antagonist for Nebulized Therapy, in Patients With Markers of More Severe COPD: A Post Hoc Subgroup Analysis." BMC Pulm Med 2020.